Provided by Tiger Trade Technology Pte. Ltd.

CAR-T Concept

1,629.77
-20.9905-1.27%
Number of Gainers:- -
Number of Losers:2
Number of Flat:- -
PE:- -
High:1,664.99
Open:1,655.45
Low:1,622.74
Close:1,650.76
Volume:8.28M
Turnover:1.04B
Market Cap:423.56B
Float Cap:410.24B

Loading ...

Gilead Sciences Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
11 hours ago

Gilead voluntarily recalls one lot of Veklury for Injection 100 mg/vial

TIPRANKS
·
16 hours ago

Gilead : RBC Cuts Target Price to $100 From $105

THOMSON REUTERS
·
Yesterday

European Pharma Stocks Follow Asian, U.S. Peers Higher -- Market Talk

Dow Jones
·
Jan 07

Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jan 07

Novartis Raised to Equal-Weight From Underweight by Barclays

Dow Jones
·
Jan 07

BUZZ-Citi sees momentum in US pharma and biotech into 2026, updates ratings on top picks

Reuters
·
Jan 06

Onconano Medicine Announces Research Collaboration With Gilead to Apply on-Board™ Delivery Technology to Gilead’s Drug Candidate

THOMSON REUTERS
·
Jan 06

Onconano Medicine: Gilead Has Option to Expand Deal by Nominating Additional Target for on-Board Technology, in Which Co Would Receive up to $300 Mln

THOMSON REUTERS
·
Jan 06

Gilead Sciences Partners with OncoNano Medicine to Develop Tumor-Targeted Drug Delivery

Reuters
·
Jan 06

Heard on the Street: Big Pharma Has More Going for It Than Obesity Drugs -- WSJ

Dow Jones
·
Jan 06

Biotech and Pharma Stocks Tumble as Investors Race into Energy -- Barrons.com

Dow Jones
·
Jan 06

What's Going On With Royalty Pharma Stock Wednesday?

Benzinga
·
Dec 31, 2025

Market Chatter: Pfizer, GSK, Others to Raise US Prices on 350 Drugs in 2026

MT Newswires Live
·
Dec 31, 2025

Gilead Sciences Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Dec 31, 2025

Gilead Sciences CEO Daniel O’Day Reports Sale of Common Shares

Reuters
·
Dec 31, 2025

BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EST on 2025-12-30

Reuters
·
Dec 31, 2025